1 Study Coverage 1.1 Tuberculosis Vaccine Treatment Product Introduction 1.2 Market by Type 1.2.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type 1.4.2 Immune Vaccine 1.4.3 Therapy Vaccine 1.3 Market by Application 1.3.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application 1.3.2 Self-Procurement 1.3.3 UNICEF 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts 2016-2027 2.2 Global Tuberculosis Vaccine Treatment Revenue Estimates and Forecasts 2016-2027 2.3 Global Tuberculosis Vaccine Treatment Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Tuberculosis Vaccine Treatment Regions by Sales 2.4.1 Global Top Tuberculosis Vaccine Treatment Regions by Sales (2016-2021) 2.4.2 Global Top Tuberculosis Vaccine Treatment Regions by Sales (2022-2027) 2.5 Global Top Tuberculosis Vaccine Treatment Regions by Revenue 2.5.1 Global Top Tuberculosis Vaccine Treatment Regions by Revenue (2016-2021) 2.5.2 Global Top Tuberculosis Vaccine Treatment Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers 3.1.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Sales (2016-2021) 3.1.2 Global Top Tuberculosis Vaccine Treatment Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Sales in 2020 3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers 3.2.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Tuberculosis Vaccine Treatment Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2020 3.3 Global Tuberculosis Vaccine Treatment Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Tuberculosis Vaccine Treatment Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Tuberculosis Vaccine Treatment Sales by Type 4.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Type (2016-2021) 4.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Type (2022-2027) 4.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) 4.2 Global Tuberculosis Vaccine Treatment Revenue by Type 4.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Type (2016-2021) 4.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Type (2022-2027) 4.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) 4.3 Global Tuberculosis Vaccine Treatment Price by Type 4.3.1 Global Tuberculosis Vaccine Treatment Price by Type (2016-2021) 4.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Tuberculosis Vaccine Treatment Sales by Application 5.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Application (2016-2021) 5.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Application (2022-2027) 5.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) 5.2 Global Tuberculosis Vaccine Treatment Revenue by Application 5.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Application (2016-2021) 5.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Application (2022-2027) 5.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) 5.3 Global Tuberculosis Vaccine Treatment Price by Application 5.3.1 Global Tuberculosis Vaccine Treatment Price by Application (2016-2021) 5.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Application (2022-2027) 6 North America 6.1 North America Tuberculosis Vaccine Treatment Market Size by Type 6.1.1 North America Tuberculosis Vaccine Treatment Sales by Type (2016-2027) 6.1.2 North America Tuberculosis Vaccine Treatment Revenue by Type (2016-2027) 6.2 North America Tuberculosis Vaccine Treatment Market Size by Application 6.2.1 North America Tuberculosis Vaccine Treatment Sales by Application (2016-2027) 6.2.2 North America Tuberculosis Vaccine Treatment Revenue by Application (2016-2027) 6.3 North America Tuberculosis Vaccine Treatment Market Size by Country 6.3.1 North America Tuberculosis Vaccine Treatment Sales by Country (2016-2027) 6.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Tuberculosis Vaccine Treatment Market Size by Type 7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2027) 7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Type (2017-2027) 7.2 Europe Tuberculosis Vaccine Treatment Market Size by Application 7.2.1 Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2027) 7.2.2 Europe Tuberculosis Vaccine Treatment Revenue by Application (2017-2027) 7.3 Europe Tuberculosis Vaccine Treatment Market Size by Country 7.3.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2027) 7.3.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Type 8.1.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Type (2018-2027) 8.1.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Type (2018-2027) 8.2 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Application 8.2.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Application (2018-2027) 8.2.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Application (2018-2027) 8.3 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Region 8.3.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2018-2027) 8.3.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Tuberculosis Vaccine Treatment Market Size by Type 9.1.1 Latin America Tuberculosis Vaccine Treatment Sales by Type (2019-2027) 9.1.2 Latin America Tuberculosis Vaccine Treatment Revenue by Type (2019-2027) 9.2 Latin America Tuberculosis Vaccine Treatment Market Size by Application 9.2.1 Latin America Tuberculosis Vaccine Treatment Sales by Application (2019-2027) 9.2.2 Latin America Tuberculosis Vaccine Treatment Revenue by Application (2019-2027) 9.3 Latin America Tuberculosis Vaccine Treatment Market Size by Country 9.3.1 Latin America Tuberculosis Vaccine Treatment Sales by Country (2019-2027) 9.3.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Type 6.1.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2027) 6.1.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Type (2016-2027) 6.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Application 6.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2027) 6.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Application (2016-2027) 6.3 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country 6.3.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2027) 6.3.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Overview 11.1.3 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Merck Tuberculosis Vaccine Treatment Product Description 11.1.5 Merck Related Developments 11.2 Japan BCG Lab 11.2.1 Japan BCG Lab Corporation Information 11.2.2 Japan BCG Lab Overview 11.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Description 11.2.5 Japan BCG Lab Related Developments 11.3 Serum Institute of India 11.3.1 Serum Institute of India Corporation Information 11.3.2 Serum Institute of India Overview 11.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Description 11.3.5 Serum Institute of India Related Developments 11.4 AJ Vaccines 11.4.1 AJ Vaccines Corporation Information 11.4.2 AJ Vaccines Overview 11.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Description 11.4.5 AJ Vaccines Related Developments 11.5 BioFarma 11.5.1 BioFarma Corporation Information 11.5.2 BioFarma Overview 11.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 BioFarma Tuberculosis Vaccine Treatment Product Description 11.5.5 BioFarma Related Developments 11.6 GreenSignal Bio Pharma 11.6.1 GreenSignal Bio Pharma Corporation Information 11.6.2 GreenSignal Bio Pharma Overview 11.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Description 11.6.5 GreenSignal Bio Pharma Related Developments 11.7 China National Biotec 11.7.1 China National Biotec Corporation Information 11.7.2 China National Biotec Overview 11.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Description 11.7.5 China National Biotec Related Developments 11.8 Biomed Lublin 11.8.1 Biomed Lublin Corporation Information 11.8.2 Biomed Lublin Overview 11.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Description 11.8.5 Biomed Lublin Related Developments 11.9 Taj Pharmaceuticals 11.9.1 Taj Pharmaceuticals Corporation Information 11.9.2 Taj Pharmaceuticals Overview 11.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Description 11.9.5 Taj Pharmaceuticals Related Developments 11.10 Ataulpho de Paiva 11.10.1 Ataulpho de Paiva Corporation Information 11.10.2 Ataulpho de Paiva Overview 11.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Description 11.10.5 Ataulpho de Paiva Related Developments 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Overview 11.1.3 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Merck Tuberculosis Vaccine Treatment Product Description 11.1.5 Merck Related Developments 11.12 Queen Saovabha Mem. Inst 11.12.1 Queen Saovabha Mem. Inst Corporation Information 11.12.2 Queen Saovabha Mem. Inst Overview 11.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Queen Saovabha Mem. Inst Product Description 11.12.5 Queen Saovabha Mem. Inst Related Developments 11.13 Microgen 11.13.1 Microgen Corporation Information 11.13.2 Microgen Overview 11.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Microgen Product Description 11.13.5 Microgen Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Tuberculosis Vaccine Treatment Value Chain Analysis 12.2 Tuberculosis Vaccine Treatment Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Tuberculosis Vaccine Treatment Production Mode & Process 12.4 Tuberculosis Vaccine Treatment Sales and Marketing 12.4.1 Tuberculosis Vaccine Treatment Sales Channels 12.4.2 Tuberculosis Vaccine Treatment Distributors 12.5 Tuberculosis Vaccine Treatment Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Tuberculosis Vaccine Treatment Industry Trends 13.2 Tuberculosis Vaccine Treatment Market Drivers 13.3 Tuberculosis Vaccine Treatment Market Challenges 13.4 Tuberculosis Vaccine Treatment Market Restraints 14 Key Findings in The Global Tuberculosis Vaccine Treatment Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Immune Vaccine Table 3. Major Manufacturers of Therapy Vaccine Table 4. Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Tuberculosis Vaccine Treatment Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose) Table 7. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021) Table 8. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose) Table 9. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2022-2027) Table 10. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021) Table 12. Global Tuberculosis Vaccine Treatment Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2022-2027) Table 14. Global Tuberculosis Vaccine Treatment Sales by Manufacturers (2016-2021) & (K Dose) Table 15. Global Tuberculosis Vaccine Treatment Sales Share by Manufacturers (2016-2021) Table 16. Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers (2016-2021) Table 18. Tuberculosis Vaccine Treatment Price by Manufacturers 2016-2021 (USD/K Dose) Table 19. Global Tuberculosis Vaccine Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2020) Table 21. Tuberculosis Vaccine Treatment Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Tuberculosis Vaccine Treatment Product Offered Table 23. Date of Manufacturers Enter into Tuberculosis Vaccine Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 26. Global Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 27. Global Tuberculosis Vaccine Treatment Sales Share by Type (2016-2021) Table 28. Global Tuberculosis Vaccine Treatment Sales Share by Type (2022-2027) Table 29. Global Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2016-2021) Table 32. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2022-2027) Table 33. Tuberculosis Vaccine Treatment Price by Type (2016-2021) & (USD/K Dose) Table 34. Global Tuberculosis Vaccine Treatment Price Forecast by Type (2022-2027) & (USD/K Dose) Table 35. Global Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 36. Global Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 37. Global Tuberculosis Vaccine Treatment Sales Share by Application (2016-2021) Table 38. Global Tuberculosis Vaccine Treatment Sales Share by Application (2022-2027) Table 39. Global Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2016-2021) Table 42. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2022-2027) Table 43. Tuberculosis Vaccine Treatment Price by Application (2016-2021) & (USD/K Dose) Table 44. Global Tuberculosis Vaccine Treatment Price Forecast by Application (2022-2027) & (USD/K Dose) Table 45. North America Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 46. North America Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 47. North America Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 50. North America Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 51. North America Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 54. North America Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose) Table 55. North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 58. Europe Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 59. Europe Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 62. Europe Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 63. Europe Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 66. Europe Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose) Table 67. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 70. Asia Pacific Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 71. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 74. Asia Pacific Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 75. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose) Table 78. Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2022-2027) & (K Dose) Table 79. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 82. Latin America Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 83. Latin America Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 86. Latin America Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 87. Latin America Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 90. Latin America Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose) Table 91. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose) Table 94. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2022-2027) & (K Dose) Table 95. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose) Table 98. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2022-2027) & (K Dose) Table 99. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose) Table 102. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2022-2027) & (K Dose) Table 103. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2022-2027) & (US$ Million) Table 105. Merck Corporation Information Table 106. Merck Description and Major Businesses Table 107. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 108. Merck Tuberculosis Vaccine Treatment Product Table 109. Merck Recent Developments Table 110. Japan BCG Lab Corporation Information Table 111. Japan BCG Lab Description and Major Businesses Table 112. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 113. Japan BCG Lab Tuberculosis Vaccine Treatment Product Table 114. Japan BCG Lab Recent Developments Table 115. Serum Institute of India Corporation Information Table 116. Serum Institute of India Description and Major Businesses Table 117. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 118. Serum Institute of India Tuberculosis Vaccine Treatment Product Table 119. Serum Institute of India Recent Developments Table 120. AJ Vaccines Corporation Information Table 121. AJ Vaccines Description and Major Businesses Table 122. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 123. AJ Vaccines Tuberculosis Vaccine Treatment Product Table 124. AJ Vaccines Recent Developments Table 125. BioFarma Corporation Information Table 126. BioFarma Description and Major Businesses Table 127. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 128. BioFarma Tuberculosis Vaccine Treatment Product Table 129. BioFarma Recent Developments Table 130. GreenSignal Bio Pharma Corporation Information Table 131. GreenSignal Bio Pharma Description and Major Businesses Table 132. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 133. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Table 134. GreenSignal Bio Pharma Recent Developments Table 135. China National Biotec Corporation Information Table 136. China National Biotec Description and Major Businesses Table 137. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 138. China National Biotec Tuberculosis Vaccine Treatment Product Table 139. China National Biotec Recent Developments Table 140. Biomed Lublin Corporation Information Table 141. Biomed Lublin Description and Major Businesses Table 142. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 143. Biomed Lublin Tuberculosis Vaccine Treatment Product Table 144. Biomed Lublin Recent Developments Table 145. Taj Pharmaceuticals Corporation Information Table 146. Taj Pharmaceuticals Description and Major Businesses Table 147. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 148. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Table 149. Taj Pharmaceuticals Recent Developments Table 150. Ataulpho de Paiva Corporation Information Table 151. Ataulpho de Paiva Description and Major Businesses Table 152. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 153. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Table 154. Ataulpho de Paiva Recent Developments Table 155. IVAC Corporation Information Table 156. IVAC Description and Major Businesses Table 157. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 158. IVAC Tuberculosis Vaccine Treatment Product Table 159. IVAC Recent Developments Table 160. Queen Saovabha Mem. Inst Corporation Information Table 161. Queen Saovabha Mem. Inst Description and Major Businesses Table 162. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 163. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Table 164. Queen Saovabha Mem. Inst Recent Developments Table 165. Microgen Corporation Information Table 166. Microgen Description and Major Businesses Table 167. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2016-2021) Table 168. Microgen Tuberculosis Vaccine Treatment Product Table 169. Microgen Recent Developments Table 170. Key Raw Materials Lists Table 171. Raw Materials Key Suppliers Lists Table 172. Tuberculosis Vaccine Treatment Distributors List Table 173. Tuberculosis Vaccine Treatment Customers List Table 174. Tuberculosis Vaccine Treatment Market Trends Table 175. Tuberculosis Vaccine Treatment Market Drivers Table 176. Tuberculosis Vaccine Treatment Market Challenges Table 177. Tuberculosis Vaccine Treatment Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Treatment Product Picture Figure 2. Global Tuberculosis Vaccine Treatment Market Share by Type in 2020 & 2027 Figure 3. Immune Vaccine Product Picture Figure 4. Therapy Vaccine Product Picture Figure 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020 & 2027 Figure 6. Self-Procurement Figure 7. UNICEF Figure 8. Other Figure 9. Tuberculosis Vaccine Treatment Report Years Considered Figure 10. Global Tuberculosis Vaccine Treatment Sales 2016-2027 (K Dose) Figure 11. Global Tuberculosis Vaccine Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Tuberculosis Vaccine Treatment Revenue 2016-2027 (US$ Million) Figure 13. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 14. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021) Figure 15. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2022-2027) Figure 16. North America Tuberculosis Vaccine Treatment Sales YoY (2016-2027) & (K Dose) Figure 17. North America Tuberculosis Vaccine Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 18. Europe Tuberculosis Vaccine Treatment Sales YoY (2016-2027) & (K Dose) Figure 19. Europe Tuberculosis Vaccine Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 20. Asia-Pacific Tuberculosis Vaccine Treatment Sales YoY (2016-2027) & (K Dose) Figure 21. Asia-Pacific Tuberculosis Vaccine Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 22. Latin America Tuberculosis Vaccine Treatment Sales YoY (2016-2027) & (K Dose) Figure 23. Latin America Tuberculosis Vaccine Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 24. Middle East & Africa Tuberculosis Vaccine Treatment Sales YoY (2016-2027) & (K Dose) Figure 25. Middle East & Africa Tuberculosis Vaccine Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 26. The Top 10 and Top 5 Players Market Share by Tuberculosis Vaccine Treatment Sales in 2020 Figure 27. The Top 10 and Top 5 Players Market Share by Tuberculosis Vaccine Treatment Revenue in 2020 Figure 28. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 30. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 31. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 32. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 33. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 34. North America Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 35. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 36. North America Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 37. North America Tuberculosis Vaccine Treatment Sales Share by Country (2016-2027) Figure 38. North America Tuberculosis Vaccine Treatment Revenue Share by Country (2016-2027) Figure 39. U.S. Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 40. Canada Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 41. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 42. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 43. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 44. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 45. Europe Tuberculosis Vaccine Treatment Sales Share by Country (2016-2027) Figure 46. Europe Tuberculosis Vaccine Treatment Revenue Share by Country (2016-2027) Figure 47. Germany Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 48. France Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 49. U.K. Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 50. Italy Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 51. Russia Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 52. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 53. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 54. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 55. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 56. Asia Pacific Tuberculosis Vaccine Treatment Sales Share by Region (2016-2027) Figure 57. Asia Pacific Tuberculosis Vaccine Treatment Revenue Share by Region (2016-2027) Figure 58. China Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 59. Japan Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 60. South Korea Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 61. India Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 62. Australia Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 63. Taiwan Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 64. Indonesia Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 65. Thailand Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 66. Malaysia Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 67. Philippines Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 68. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 69. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 70. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 71. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 72. Latin America Tuberculosis Vaccine Treatment Sales Share by Country (2016-2027) Figure 73. Latin America Tuberculosis Vaccine Treatment Revenue Share by Country (2016-2027) Figure 74. Mexico Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 75. Brazil Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 76. Argentina Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 77. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027) Figure 78. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027) Figure 79. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027) Figure 80. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027) Figure 81. Middle East and Africa Tuberculosis Vaccine Treatment Sales Share by Country (2016-2027) Figure 82. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Share by Country (2016-2027) Figure 83. Turkey Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 84. Saudi Arabia Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 85. UAE Tuberculosis Vaccine Treatment Revenue (2016-2027) & (US$ Million) Figure 86. Tuberculosis Vaccine Treatment Value Chain Figure 87. Tuberculosis Vaccine Treatment Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

Merck Japan BCG Lab Serum Institute of India AJ Vaccines BioFarma GreenSignal Bio Pharma China National Biotec Biomed Lublin Taj Pharmaceuticals Ataulpho de Paiva IVAC Queen Saovabha Mem. Inst Microgen